Search results
BioNTech SE (NASDAQ:BNTX) Shares Sold by Robeco Institutional Asset Management B.V.
ETF DAILY NEWS· 4 days agoRobeco Institutional Asset Management B.V. lowered its position in BioNTech SE (NASDAQ:BNTX – Free Report) by 18.8% in the fourth quarter, HoldingsChannel reports. The fund ...
Investors Buy High Volume of BioNTech Call Options (NASDAQ:BNTX)
ETF DAILY NEWS· 6 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) was the recipient of some unusual options trading on Wednesday. Traders bought 2,346 call options on the stock
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 14 hours agoSo, all in all, is PFE stock a buy or a sell right now? Pfizer Stock Fundamentals: 'Massive' Upside...
BioNTech (NASDAQ:BNTX) Shares Up 6.1%
ETF DAILY NEWS· 6 days agoBioNTech SE (NASDAQ:BNTX – Get Free Report) shares shot up 6.1% during trading on Wednesday . 657,251 shares were traded during mid-day trading, an increase of 4% from the ...
Why Vaccine Stocks Rallied This Week
Motley Fool via Yahoo Finance· 6 days agoFurthermore, the company just inked a landmark partnership and licensing deal with French pharmaceutical giant ...workers directly exposed to infected...
Vaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines By Investing.com
Investing.com· 7 days agoVaccine stocks gain, Moderna and Pfizer in talks with the US on bird flu vaccines
Heard on the Street: Moderna Got a Boost From Bird Flu, but Don’t Count Your Chicks
The Wall Street Journal· 7 days agoModerna, BioNTech, CureVac and Novavax have added billions of dollars in combined market...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 6 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...
Jim Cramer: Celestica Makes A 'Comeback,' Sell This Movie Theater Stock, - Moderna (NASDAQ:MRNA)
Benzinga· 2 days agoJim Cramer called Celestica Inc. "terrific" after the Toronto-based company reported...
Moderna Stock Is Having Another Very Bad Day. Here’s Why.
Barrons.com· 19 hours agoThe drop comes as Moderna awaits important developments involving its experimental cancer treatment,...